Tuesday, 21 July 2026
  
Login

Australia's most trusted
source of pharma news

Tuesday, 21 July 2026
News

Aussie joins the US$1 billion club

Posted 21 July 2026 PM

Telix is predicting revenues of more than a billion US dollars for the calendar year 2026, which would be a 25 per cent increase on 2025.

After releasing its second quarter results Telix said it expects revenue for the year to be at the upper end of the guidance of $1.355-1.384 billion (US$950-970 million), with the addition of $57 million (US$40 million) from a deal with Regeneron.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (19)

Access & Reimbursement (1)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (4)

Other (13)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.